Elevate Clinical Research Solutions Announces Launch of "Train and Build" Service Line and Webinar Series

January 22, 2025 10:00 AM

Elevate Clinical Research Solutions is proud to announce the launch of its latest service line, "Train and Build", designed to address the pressing operational challenges faced by clinical research sites. Alongside this initiative, Elevate is hosting a Train & Build Webinar Series, a five-part program aimed at empowering research professionals with actionable insights and expert guidance. The series kicked off on November 20, 2024, with...

Read more

KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus

January 22, 2025 9:00 AM

SALT LAKE CITY, UT / ACCESS Newswire / January 22, 2025 / KindlyMD ("KindlyMD" or the "Company") (NASDAQ:KDLY), a leading provider of integrated healthcare services, today announced the opening of a new integrated behavioral health clinic location on the campus of Ogden Regional Medical Center, a MountainStar hospital owned by HCA Healthcare."We are excited to open our new location on the campus of Ogden Regional Medical Center in Utah," said...

Read more

Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease (MVID), with Proof-of-Concept (POC) Data Potentially Available H1 2025

January 22, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today announced that the first patient has been dosed in the independent investigator-initiated POC trial of crofelemer, Jaguar's novel plant-based anti-diarrheal prescription drug, for the rare disease indication of MVID in pediatric patients. POC data generated from this study potentially in the first half of 2025 could lead to...

Read more

New Natural Sleep Aid Innovation Combines Traditional Ingredients With Modern Science

January 22, 2025 9:00 AM

Perfiby, a California-based wellness company, today announced the launch of its innovative Sleep Aid Capsule, combining elderberry extract with scientifically-proven sleep-supporting ingredients. The GMP-certified supplement aims to address the growing concern of sleep quality in America, where an estimated 70 million adults suffer from sleep disorders.The new sleep aid formula features a carefully calibrated blend of natural ingredients,...

Read more

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

January 22, 2025 8:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others,...

Read more

Ursamin Pilots Achieve Measurable Results in Streamlining Care Coordination Workflows

January 22, 2025 8:00 AM

Ursamin (ursamin.com), a healthcare technology company focused on breaking down barriers that impede effective care coordination, announces the completion of its pilot program focused on family medicine in primary care. The program demonstrates that new technology workflows streamline processes, reduce reliance on paper, and improve visibility into patient needs. This empowers clinicians to spend more time delivering patient care, leading to...

Read more

CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback

January 22, 2025 8:00 AM

SCOTTSDALE, AZ / ACCESS Newswire / January 22, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD and wellness industries, is proud to announce a transformative financial milestone-the successful reduction of its authorized share count by an extraordinary 3.5 billion shares, with Transfer Agent Approval. This reduction represents a monumental step forward in the company's ongoing commitment to optimizing its capital...

Read more

Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

January 22, 2025 8:00 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2,007,880 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 2,007,880 shares of...

Read more

Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR

January 22, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced interim data from its second clinical trial to evaluate PF614-MPAR for overdose protection. Clinical study PF614-MPAR-102, ‘A Single and Multiple Dose Study to Evaluate the Pharmacokinetics of Oxycodone and...

Read more

DEA Anti-marijuana Swamp Draining - Impact of Schedule F - MMJ Litigation Continues

January 22, 2025 6:00 AM

The recent resignation of Anne Milgram as DEA Administrator marks a pivotal shift in the agency's leadership dynamics. This change is part of a broader sweep through the DEA's ranks, with Tom Prevoznik and Matt Strait anticipated as the next officials potentially on the chopping block. This transition comes amid criticisms of an entrenched anti-marijuana bias within the DEA, suggesting a significant shake-up under the new administration aimed at...

Read more

3D Printed Surgical Models Market is projected to Reach USD 2,589.0 million, with a 15.6% of CAGR from 2025 to 2035, Rapid Growth Driven by Technological Advancements and Precision Medicine

January 22, 2025 4:00 AM

The global 3D printed surgical models market is expected to grow at a remarkable rate, from USD 607.5 million in 2025 to USD 2,589.0 million by 2035, with a strong compound annual growth rate of 15.6%. This growth trajectory is a reflection of the increasing adoption of 3D printing technology in healthcare, especially in personalized patient care and surgical planning.The demand for 3D printed surgical models is being driven by their ability to...

Read more

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases

January 22, 2025 2:00 AM

Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced that, together with Yonsei University and the Korean biotech company Zymedi, it will receive a US$ 4.5m grant from the Korea Institute of Advanced Technology (KIAT). The KIAT grant will fund the development of first-in-class biologic therapies to treat lung diseases, including asthma and idiopathic pulmonary fibrosis (IPF). The project will focus on...

Read more

Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US

January 22, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the sale of its intellectual property and commercialization rights for GOLIKE outside the United States to Nutrisens, a leading independent platform that develops and commercializes clinical nutrition solutions...

Read more

Salignostics Advances Saliva-Based HIV Testing with Successful Clinical Trial in Ethiopia

January 21, 2025 6:45 PM

Salignostics, a leader in saliva-based diagnostic innovation, proudly announces the successful completion of a clinical trial in Ethiopia for its groundbreaking saliva-based HIV rapid test. This major milestone brings Salignostics closer to providing a transformative solution for HIV testing, particularly in areas with limited access to healthcare infrastructure.The trial, conducted in November 2024, evaluated 50 saliva samples from individuals...

Read more

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

January 21, 2025 6:00 PM

MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin clinical trials for new label claim applications of its recently Health Canada approved Multiplo® TP/HIV rapid test. These applications include use as a self-test and for non-professional administration, expanding access to testing for syphilis and HIV in Canada.More testing options are urgently needed...

Read more

NHI Announces Fourth Quarter 2024 Earnings Release and Conference Call Dates

January 21, 2025 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the fourth quarter ended December 31, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, February 25, 2025, and will host a conference call on the following day, Wednesday, February 26, 2025, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with...

Read more

Top 100 Healthcare IT Consultant Project Areas in Highest Demand: Leading Advisory Firms Driving the Future of Healthcare Innovation

January 21, 2025 4:00 PM

Black Book Research has unveiled the top 100 healthcare IT advisory services projected to experience the highest demand in 2025. This comprehensive analysis is based on insights drawn from over 5,100 engagements conducted since 2019 across U.S. hospitals, health systems, payers, and physician organizations. Each engagement was rigorously evaluated over the five-year period using six Key Performance Indicators (KPIs) that measure business impact...

Read more

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

January 21, 2025 3:00 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its CEO, Greg Siokas, has increased his stake in the Company by acquiring a total of 647,809 common shares, valued...

Read more

UnisLink Approved as Qualified Clinical Data Registry by CMS for 2025 MIPS Reporting Program

January 21, 2025 2:00 PM

UnisLink, a national leader in revenue cycle management (RCM) solutions, is thrilled to announce its recent approval by the Centers for Medicare & Medicaid Services (CMS) as a Qualified Clinical Data Registry (QCDR) for the 2025 Merit-based Incentive Payment System (MIPS) reporting program.This significant achievement underscores UnisLink's commitment to enhancing healthcare organizations' operational efficiency and billing accuracy. As a QCDR,...

Read more

Belhaven Biopharma Raises $11M to Advance Nasdepi(R): The Dry Powder Nasal Breakthrough for Anaphylaxis

January 21, 2025 1:05 PM

Belhaven Biopharma, a leader in dry powder nasal drug delivery systems, announces the launch of a new clinical study designed to evaluate the commercial dose of Nasdepi®, an epinephrine product for intranasal administration, and further establish its potential as a transformative treatment for severe allergic reactions.Belhaven also announces the completion of its fourth funding round, which closed oversubscribed at $11 million, exceeding the...

Read more